MicroRNA-663 targets TGFB1 and regulates lung cancer proliferation

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 11, 2011, Pages 2819-2823

  Zhi Yong, Liu ^a   Guang Ling, Zhang ^a   Mei Mei, Wang ^a   Ya Nan, Xiong ^a   He Qin, Cui ^a  

^a HEBEI UNITED UNIVERSITY   (China)

Author keywords

A549; Lung cancer; miR 663; Oncogene; TGFB1

Indexed keywords

EID: 84863309949     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Tiozzo C, De Langhe S, Yu M, et al (2009). Deletion of Pten expands lung epithelial progenitor pools and confers resistance to airway injury. Am J Respir Crit Care Med, 180, 701-12.
2. Young RP, Hopkins RJ, Hay BA, et al (2009). A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers. Postgrad Med J, 85, 515-24
3. Hiyoshi Y, Kamohara H, Karashima R, et al (2009). MicroRNA-21 Regulates the Proliferation and Invasion in Esophageal Squamous Cell Carcinoma. Clin. Cancer Res, 15, 1915-22
4. Aguda B D, Kim Y, Piper-Hunter M G, et al (2008). MicroRNA regulation of a cancer network: Consequences of the feedback loops involving miR-17-92, E2F, and Myc. PNAS, 105, 19678-83
5. Mathonnet G, Fabian M R, Svitkin Y V, et al (2007). MicroRNA Inhibition of Translation Initiation in Vitro by Targeting the Cap-Binding Complex eIF4F. Science, 317, 1764-7.
6. Bartel D P (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97.
7. Agrawal R, Tran U, Wessely O (2009). The miR-30 miRNA family regulates Xenopus pronephros development and targets the transcription factor Xlim1/Lhx1. Development, 136, 3927-36.
8. Matsubara H, Takeuchi T, Nishikawa E, et al (2007). Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene, 26, 6099-105. Epub 2007 Mar 26
9. Venugopal SK, Jiang J, Kim TH, et al (2010). Liver fibrosis causes down-regulation of miRNA-150 and miRNA-194 in hepatic stellate cells and their over-expression causes decreased stellate cell activation. Am J Physiol Gastrointest Liver Physiol, 298, G101-6.
10. Osada H, Takahashi T (2007). MicroRNAs in biological processes and carcinogenesis. Carcinogenesis, 28, 2-12.
11. Elliott RL, Blobe GC (2005). Role of transforming growth factor β in human cancer. J Clin Oncol, 23, 2078-93
12. Datto MB, Li Y, Panus JF, et al (1995). Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci U S A, 92, 5545-9.
13. Berndt SI, Huang WY, Chatterjee N, et al (2007). Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma. Carcinogenesis, 28, 1965-70.
14. Mao JH, Saunier EF, de Koning JP, et al (2006). Genetic variants of Tgfb1 act as context-dependent modifiers of mouse skin tumor susceptibility. Proc Natl Acad Sci U S A, 103, 8125-30.
15. Aluwihare P, Mu Z, Zhao Z, et al (2009). Mice that lack activity of alphavbeta6- and alphavbeta8-integrins reproduce the abnormalities of Tgfb1- and Tgfb3-null mice. J Cell Sci, 122, 227-32.
16. Wrana JL, Attisano L, Wieser R, et al (1994). Mechanism of activation of the TGF-beta receptor. Nature, 370, 341-7
17. Attisano L, Wrana JL (2002). Signal transduction by the TGF-beta superfamily. Science, 296, 1646-7
18. Shi Y, Massagué J (2003). Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell, 113, 685-700
19. Nakao A, Imamura T, Souchelnytskyi S, et al (1997). TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J, 16, 5353-62
20. Katakura Y, Nakata E, Miura T, et al (1999). Transforming growth factor beta triggers two independent-senescence programs in cancer cells. Biochem Biophys Res Commun, 255, 110-5
21. Inman GJ, Allday MJ (2000). Apoptosis induced by TGF-beta 1 in Burkitt's lymphoma cells is caspase 8 dependent but is death receptor independent. J Immunol, 165, 2500-10
22. Ewan KB, Henshall-Powell RL, Ravani SA, et al (2002). Transforming growth factor-beta1 mediates cellular response to DNA damage in situ. Cancer Res, 62, 5627-31
23. Depoortere F, Pirson I, Bartek J, et al (2000). Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1). Mol Biol Cell, 11, 1061-76
24. Massagué J, Blain SW, Lo RS (2000). TGFbeta signaling in growth control, cancer, and heritable disorders. Cell, 103, 295-309.
25. Derynck R, Akhurst RJ, Balmain A (2001). TGF-beta signaling in tumor suppression and cancer progression. Nat Genet, 29, 117-29
26. Perera CN, Chin HG, Duru N, et al (2008). Leptin-regulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression. J Endocrinol, 199, 221-33. Epub 2008 Aug 20
27. Engle SJ, Hoying JB, Boivin GP, et al (1999). Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis. Cancer Res, 59, 3379-86.